Bevacizumab and sunitinib treatment of patients with RCC induced an increase in the total numbers of CD68+ macrophages in the primary tumors (p < 0.01 and p < 0.001 respectively, Fig. 3a-b), associated with the induction of necrosis, shown in Fig. 1b. The gene discussed is CD68; the disease is renal cell carcinoma.